Carna Biosciences will be presenting two posters at the AACR Annual Meeting 2013 held in Washington, D.C. from April 6 through 10. The one is focusing on our RPPA cell signaling analysis & technology, which was transferred from National Cancer Center and was developed as an assay service. And, another is our QSS Assist™ ELISA Assay Kit. Please check our posters out. Also, we will exhibit at the venue. Please stop by our booth, # 401.
In addition, Dr. Mari Masuda of National Cancer Center will be also presenting her own poster about the RPPA technology entitled "Genomic and proteomic profiling of signaling pathways targeted by a multi-kinase inhibitor, sorafenib" at the meeting. Please check it out.
Abstract Number: 5165 (Presented by Carna R&D)
Presentation Title: Pathway oriented phospho-proteomics analysis with reverse phase protein array (RPPA) technology in cell growth and cancer therapy
Presentation Time: Wednesday, Apr 10, 2013, 8:00 AM -12:00 PM
Location: Hall A-C, Poster Section 24, Poster Board Number: 13
Abstract Number: 4541
(Jointly presented by Novartis Pharma AG, Carna, and Carna's European agent, KinaseLogistics, ApS.)
Presentation Title: Highly sensitive kinase assays combining Carna Biosciences QSS Assist ELISA reagents with the Meso Scale Discovery MULTI-ARRAY platform
Presentation Time: Tuesday, Apr 09, 2013, 1:00 PM - 5:00 PM
Location: Hall A-C, Poster Section 44, Poster Board Number: 10
Abstract Number: 4654
(Presented by Dr. Mari Masuda of National Cancer Center, Research Institution, Tokyo, Japan)
Presentation Title: Genomic and proteomic profiling of signaling pathways targeted by a multi-kinase inhibitor, sorafenib
Presentation Time: Wednesday, Apr 10, 2013, 8:00 AM -12:00 PM
Location: Hall A-C, Poster Section 1, Poster Board Number: 15